雇佣兵
发表于 2025-3-30 10:32:47
http://reply.papertrans.cn/43/4284/428312/428312_51.png
GRATE
发表于 2025-3-30 15:03:28
http://reply.papertrans.cn/43/4284/428312/428312_52.png
grieve
发表于 2025-3-30 17:20:50
http://reply.papertrans.cn/43/4284/428312/428312_53.png
construct
发表于 2025-3-31 00:26:29
Book 2022g the imaging and drug delivery functions in one single nanoformulation, providing vital insights into the identification of tumour and predicting the efficacy of nanomedicine. For its unique properties, which include their small size and biocompatibility and ability to permeate the cellular membran
典型
发表于 2025-3-31 01:53:20
Progress of Cancer Nano Medicine, Clinical Hurdles, and Opportunities,rteries and accumulate in plasma at high levels. In this chapter, we will look at the advancements of nanomedicine in all areas of pharmaceuticals. We will also discuss the challenges encountered during clinical testing and development of cancer medicines, as well as future opportunities.
荧光
发表于 2025-3-31 06:25:12
Challenges and Opportunities in the Delivery of Oral Anticancer Therapeutics,ilability, pharmacokinetics, and biodistribution profiles. Here, we define the drug delivery challenges related to oral routes of administration and review innovative DDS, marketed or in development, that answer those challenges.
Ophthalmoscope
发表于 2025-3-31 11:19:43
Nanocarriers-Based Targeted Therapies for Pancreatic Cancer and Challenges Ahead,sis. Recently, significant attempts have been made to provide targeted-based nanocarriers to treat pancreatic cancer. This chapter tries to give information about the new possibilities of targeting pancreatic cancer via nanocarriers and challenges ahead.